Indonesia 3D Imaging Market Analysis Report 2022 to 2030

Indonesia 3D Imaging Market Analysis

$ 3999

Indonesia's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the government's increasing focus on the healthcare sector and the rising number of private hospitals and clinics. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.

ID: IN10IDDH001 CATEGORY: Digital Health GEOGRAPHY: Indonesia AUTHOR: Vidhi Upadhyay

Buy Now

Indonesia 3D Imaging Market Executive Summary

Indonesia's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. According to the World Health Organization's Global Health Expenditure database, Indonesian health expenditure per capita increased from $111.66 in 2018 to $120.12 in 2019. Healthcare spending (as a percentage of GDP) has been relatively low in contrast to other countries in the region. Although the government has increased healthcare funding in recent years, there is still a significant inequality in access to healthcare and the quality of care in rural and low-income communities. According to The Global Cancer Observatory 2020, out of a total population of 273 Mn, the number of new cases of cancer was 0.4 Mn with 0.23 Mn deaths. National health studies in Indonesia, which has a population of over 270 million people, have revealed that more than 25% of the general population has hypertension, 30% have high cholesterol and are overweight, 7% have diabetes, 65% of males smoke, and 23% are inadequately physically active.

The Indonesian 3D imaging market is expanding due to rising demand for improved imaging technologies. The market is being pushed by increased awareness of the benefits of early detection, increased medical tourism, and an increase in the number of hospitals and clinics equipped with modern imaging technologies. Computed Tomography (CT), Magnetic Resonance imaging (MRI), Positron Emission Tomography (PET), and Ultrasound are the primary categories of the Indonesian 3D imaging market. CT and MRI are the most widely utilized imaging modalities in Indonesia, with many hospitals and clinics investing in these technologies.

In February 2023, Abdul Latif Jameel Health, made a distribution agreement with iSono Health, to launch a portable 3D ultrasound breast imaging scanner called “ATUSA scanner” across 31 countries including Indonesia. It is the world’s 1^st AI-driven portable 3D Breast ultrasound scanner.

Market Dynamics

Market Growth Drivers

The demand for 3D imaging technology in Indonesia has risen as people become more aware of the benefits of early and precise diagnosis. The growing number of private hospitals and clinics in Indonesia is propelling the 3D imaging industry forward. To attract patients and deliver high-quality care, private hospitals, and clinics are investing in modern imaging technology. Indonesia is a growing health tourism hub, attracting people from all over the world with its high-quality, low-cost medical treatments. As a result, the country's demand for modern imaging technology has risen. Moreover, government initiatives to strengthen the country's healthcare infrastructure and advances in 3D imaging technology have enabled the development of more efficient and cost-effective imaging systems. This has reduced the cost and availability of the use of 3D imaging, making it more widely available to patients in Indonesia.

Market Restraints

The high cost of equipment is a key impediment to the growth of the 3D imaging industry in Indonesia. The cost of 3D imaging equipment is much greater than that of standard imaging systems, making an investment in this technology challenging for many hospitals and clinics. Moreover, the lack of skilled technicians to operate and maintain 3D imaging equipment and limited reimbursement regulations for imaging operations in Indonesia may have an influence on the demand for 3D imaging since many patients may be unable to afford the costs of these procedures. Power outages and inadequate internet access can influence the availability and reliability of 3D imaging equipment. Traditional imaging techniques, such as X-rays and ultrasound, continue to be widely utilized in Indonesia and may compete with 3D imaging systems. Traditional systems are usually less expensive and more readily available, making them a preferred alternative for many patients and healthcare practitioners.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Fujifilm Medical Systems
Canon Medical Systems Corporation
PT Adira Quantum Radiology (IDN)

Notable Deals

November 2022: At RSNA, Philips introduces new AI-enhanced informatics solutions having an integrated diagnostic strategy that combines radiology, cardiology, pathology, and oncology to securely unify data and pictures throughout the organization, allowing for an earlier and more conclusive diagnosis.

November 2022: GE HealthCare has announced partnerships with Accuray, Elekta, and RaySearch to combine GE HealthCare's imaging capabilities with precision radiation therapy to give cancer patients early diagnosis and improved treatment alternatives.

March 2022: Siemens Healthineers introduced its solutions in MRI and CT portfolio- MAGNETOM Free.Star and NAEOTOM Alpha®.

Healthcare Policies and Regulatory Landscape

In Indonesia, The Ministry of Health is in charge of developing standards and regulations for imaging technology, including 3D imaging systems. They also supervise imaging equipment certification and ensure that it satisfies safety and quality requirements.

Badan Pengawas Obat dan Makanan (BOPM), The Indonesian National Agency of Drug and Food Control also regulates the usage of imaging equipment in the country. The Indonesian Radiological Technologists Association (ARTI) is another significant part of the Indonesian 3D imaging sector. ARTI is an Indonesian professional association for radiological technicians that offers training, resources, and support to professionals in the sector.

Reimbursement Scenario

The government's national healthcare insurance policy, known as the BPJS Health program, determines compensation for 3D imaging services. However, it is variable and depends on the type of imaging service opted for. The policy for 3D imaging reimbursement for those with private insurance is normally defined by the insurance company and the policyholder's unique coverage.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Indonesia 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.